Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. 1999

B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
Department of Nephrology, University Hospital, Strasbourg, France.

The objective of this study was to further characterize the clinical and immunopathologic features of heavy chain deposition disease (HCDD), a recently described entity. Four patients were diagnosed as having HCDD on a kidney biopsy. All presented with nodular glomerulosclerosis with deposition of gamma1 heavy chains lacking CH1 epitopes, but without light chains. Two different patterns were observed in the serum. First, patients 1 and 2 had a circulating monoclonal IgGlambda containing a short gamma1 heavy chain lacking CH1 epitopes, with an apparent molecular weight of 40 kD consistent with a complete CH1 deletion. Biosynthetic experiments also showed that the deleted heavy chain was produced in excess compared with light chains, and was secreted in vitro together with half Ig molecules, although these abnormal components were not detected by Western blot analysis of whole serum. Second, patients 3 and 4 had a circulating monoclonal IgG1lambda with an apparently normal, nondeleted heavy chain subunit, but serum fractionation followed by immunoblotting revealed an isolated monoclonal gamma1 chain lacking CH1 epitopes. These data strongly suggest that renal deposition of a CH1-deleted heavy chain circulating in low amounts in the serum as a free unassembled subunit is a major feature of HCDD. The CH1 deletion is most likely responsible for the premature secretion in blood of the heavy chain by a clone of plasma cells.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007161 Immunoproliferative Small Intestinal Disease A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA. Heavy Chain Disease, IgA Type,IPSID,Lymphoma, Mediterranean,alpha-Chain Disease,Disease, alpha-Chain,Diseases, alpha-Chain,Mediterranean Lymphoma,alpha Chain Disease,alpha-Chain Diseases
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D005260 Female Females
D005920 Glomerular Mesangium The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX. Mesangium, Glomerular,Mesangial Extracellular Matrix,Extracellular Matrices, Mesangial,Extracellular Matrix, Mesangial,Glomerular Mesangiums,Matrices, Mesangial Extracellular,Matrix, Mesangial Extracellular,Mesangial Extracellular Matrices,Mesangiums, Glomerular

Related Publications

B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
August 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
December 1995, Clinical nephrology,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
December 1980, Clinical and experimental immunology,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
October 1994, Kidney international,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
November 2014, CEN case reports,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
January 2015, Indian journal of nephrology,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
December 1987, Hybridoma,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
December 1999, Hematology/oncology clinics of North America,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
July 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation,
B Moulin, and S Deret, and X Mariette, and O Kourilsky, and H Imai, and L Dupouet, and L Marcellin, and I Kolb, and P Aucouturier, and J C Brouet, and P M Ronco, and B Mougenot
January 2013, Pathology international,
Copied contents to your clipboard!